09/08/2017
Zealand Pharma A/S exercises its authorization granted by its extraordinary general meeting held on July 31, 2017 in connection with its initial public offering of American Depositary Shares in the United States
With reference to the company announcement no. 29/2017, dated August 1, 2017, Zealand Pharma A/S (“Zealand”) announces that Zealand's board of directors (the "Board") has in accordance with article 7A of Zealand's articles of association exercised an authorization [...]
